Hearts from hepatitis c donors could save lives in organ shortage
NCT ID NCT03222531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether hearts from donors with hepatitis C can be safely transplanted into people without the virus. Twenty adults with end-stage heart failure on the transplant waiting list will receive these hearts and take antiviral medication to prevent infection. The goal is to expand the pool of available donor hearts and reduce wait times.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentler tug on the Heart's reins spark recovery?
- Could skipping the breathing tube make heart transplants safer?
- A Finger-Prick could change the fight against hepatitis c
- A simple finger prick could transform hepatitis c care
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can hepatitis c be cured in just 4 weeks? a new trial puts it to the test